Fibroblast Growth Patterns for Alzheimer's Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for Alzheimer's disease lack sensitivity and specificity, necessitating the development of more effective biomarkers for early and accurate diagnosis.
Innovation Solution
The use of fibroblast growth patterns, specifically through methods like integrated score, average aggregate area per number of aggregates, cell migration analysis, fractal analysis, and lacunarity analysis, to diagnose Alzheimer's disease by comparing cell cultures from human subjects to known non-Alzheimer's disease cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If current diagnostic methods are used for Alzheimer's disease, then the diagnostic process is simple, but the sensitivity and specificity are insufficient
Solution Approach 1:
The patent introduces fibroblast cells as an intermediary biomarker system. These cells are cultured from patient samples and their growth patterns serve as a mediator between the original biological sample and the diagnostic conclusion. The fibroblasts exhibit distinct growth characteristics (aggregate formation, migration patterns, fractal dimensions) that indirectly reveal Alzheimer's disease presence with high sensitivity and specificity, resolving the contradiction between diagnostic accuracy and method simplicity.
Solution Approach 2:
The patent creates a cellular copy or model of the patient's biological state through fibroblast culture. Instead of directly analyzing complex brain tissue or performing invasive procedures, the method cultivates fibroblast cells that replicate certain pathological characteristics. These cultured cells serve as a simplified copy that preserves diagnostic information while being easier to analyze, thereby improving measurement precision without proportionally increasing device complexity.
2Measurement precision
If fibroblast culture methods are implemented, then diagnostic sensitivity and specificity improve, but the diagnostic time and procedural steps increase
Solution Approach 1:
The patent performs preliminary actions by culturing fibroblast cells in advance of the actual diagnostic measurement. The cells are prepared, plated, and allowed to exhibit their growth patterns before analysis. This preliminary cultivation phase, while requiring time, simplifies the subsequent diagnostic steps and enables early detection. The advance preparation of cellular models allows for more accurate diagnostics without requiring complex real-time analysis procedures.
Data Source
AI summary
Methods of diagnosing Alzheimer's disease are provided. At least five methods of diagnostic measurements are presented: Method 1: Integrated score; Method 2: Average aggregate area per number of aggregates; Method 3: Cell migration analysis; Method 4: Fractal analysis; Method 5: Lacunarity Analysis. In certain embodiments, a sample of a subject's skin provides a network of fibroblasts that is imaged and a fractal dimension of the image is calculated. The fractal dimension can be compared to an aged-matched control (non-Alzheimer's) database to determine if the subject has Alzheimer's disease. The network of fibroblasts may be cultured in a matrix, for example in a protein mixture.